The aim of the study was to provide evidence that TGFβ1 genotypes (+869T->C, −509C->T) as modifiers of CF lung disease correlate with ex vivo TGFβ1 assessed in serum and sputum in delta F 508 homozygous CF patients. This evidence concerns the gene TGFB1 and cystic fibrosis.